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 Healthcare is in the midst of its most dramatic transformation in its history.  
The transformation is being driven by a confluence of factors.  At the macro 
level, an aging population around the world, growing prosperity in emerging 
economies, and the rise of chronic disease is putting new demands on 
healthcare systems.  Though the rate of growth of healthcare spending around 
the world has slowed in recent years, the longer-term march toward 
unsustainable levels of spending has forced governments to rethink the way 
healthcare is paid for and delivered and to scrutinize therapies through a new 
lens of value.   
 The sole practitioner, once the heart of healthcare in the United States, is 
giving way to care through integrated systems where nurse practitioners and 
physician assistants increasingly serve as a patient’s first point of medical 
contact.  Evolving scientific understandings of the molecular mechanisms of 
disease and the biology of health and wellness is leading to a new age of 
precision medicine.  The convergence of information technology, 
communications technology, and medical technology is leading to a digital 
health revolution that at one end promises new insights into how to best treat 
and protect against disease, to surveillance tools that allow unprecedented 
ability to monitor patients in their daily lives and allow doctors to intervene at 
the earliest signs of change in an individual’s health.  At the same time, these 
technologies are allowing for new ways of delivering care, whether it is a 
medical exam through a video screen or an operation using robotics where the 
surgeon is thousands of miles away from the patient.  And as cost continues to 
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shift toward the patient and recognition grows of the importance of engaging 
people in maintaining their own health and wellbeing, increasing resources are 
being developed to provide new tools to individuals to monitor their own 
health, make better informed decisions about care, and bring much needed 
transparency to costs.   
 Innovation will be critical to addressing the challenges before us, not just 
in drugs and devices, but in all aspects of healthcare services.  As pricing 
pressures increase, we will also need to take steps to ensure incentives for 
investing in and developing innovative solutions are in place and that what is 
produced does not just provide incremental improvements that provide 
enhanced abilities for greater costs, but instead disrupts the old ways of doing 
things and provides true value. 
  
